White House zeroes in on Califf to head FDA as deadline nears
A White House official said no final decision has been made. Califf declined a request for comment.
FDA is weighing a series of highly scrutinized decisions, including whether to approve coronavirus vaccines for young children, more booster shots for adults and additional treatments to fight the pandemic. The agency also is reviewing potential bans on Juul and other e-cigarette manufacturers and facing a probe into its approval of a controversial Alzheimer’s drug, among other contentious matters.
Califf, a cardiologist, served as FDA commissioner for less than a year at the end of Barack Obama’s administration, after being confirmed in an 89-4 vote in February 2016. His confirmation process faced resistance from lawmakers like Sens. Joe Manchin III (D-W.Va.) and Bernie Sanders (I-Vt.), who criticized the longtime Duke University researcher’s ties …
More on: www.washingtonpost.com